Else Nutrn Hldg (OTCMKTS:BABYF – Get Free Report) was the recipient of a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 410,109 shares, a growth of 126.7% from the April 30th total of 180,903 shares. Based on an average daily trading volume, of 469,136 shares, the short-interest ratio is presently 0.9 days. Approximately 0.9% of the company’s shares are short sold.
Else Nutrn Stock Performance
OTCMKTS BABYF opened at $0.02 on Monday. Else Nutrn has a one year low of $0.02 and a one year high of $0.80. The company’s 50 day moving average price is $0.03 and its 200 day moving average price is $0.07. The firm has a market capitalization of $958,800.00, a price-to-earnings ratio of -0.03 and a beta of 0.61.
Else Nutrn (OTCMKTS:BABYF – Get Free Report) last posted its quarterly earnings results on Friday, May 15th. The company reported ($0.03) EPS for the quarter.
Else Nutrn Company Profile
Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milk‐based formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition.
Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel.
Featured Stories
- Five stocks we like better than Else Nutrn
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Receive News & Ratings for Else Nutrn Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Else Nutrn and related companies with MarketBeat.com's FREE daily email newsletter.
